Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Perivascular Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Not applicableStudy completedNCT02009241
What this trial is testing

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
University of Sao Paulo General Hospital 40
Not applicableUnknownNCT04577937
What this trial is testing

Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis

Who this might be right for
LymphangioleiomyomatosisSleep DisorderSleep Apnea Syndromes+1 more
dr. Stefano Nava 15
Not applicableLooking for participantsNCT07304856
What this trial is testing

Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

Who this might be right for
Lymphangioleiomyomatosis (LAM)Extracellular Vesicles; Generation and Function
University of Milan 80
Testing effectiveness (Phase 2)Looking for participantsNCT07467772
What this trial is testing

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Who this might be right for
Uterine SarcomaUterine LeiomyosarcomaEndometrial Stromal Sarcoma+6 more
Dana-Farber Cancer Institute 30
Post-approval studies (Phase 4)Active Not RecruitingNCT05252585
What this trial is testing

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 4
Large-scale testing (Phase 3)Study completedNCT02180867
What this trial is testing

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Who this might be right for
Alveolar Soft Part SarcomaAngiomatoid Fibrous HistiocytomaAtypical Fibroxanthoma+33 more
National Cancer Institute (NCI) 140
Not applicableStudy completedNCT00366509
What this trial is testing

Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases

Who this might be right for
Pulmonary DiseaseOropharyngeal DiseaseLymphangioleiomyomatosis+3 more
National Heart, Lung, and Blood Institute (NHLBI) 157
Testing effectiveness (Phase 2)WithdrawnNCT03967730
What this trial is testing

Sonodynamic Therapy in the Treatment of Perivascular Adipose Tissue on Patients With PAD and Claudication

Who this might be right for
Peripheral Arterial Disease
First Affiliated Hospital of Harbin Medical University
Not applicableUnknownNCT03880045
What this trial is testing

Topical Tranexamic Acid Plus Perivascular Vasopressin at the Time of Abdominal Myomectomy

Who this might be right for
Myoma
Aswan University Hospital 100
Large-scale testing (Phase 3)Study completedNCT00414648
What this trial is testing

Efficacy and Safety of Sirolimus in LAM

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 89
Not applicableLooking for participantsNCT05676099
What this trial is testing

TSC Biosample Repository and Natural History Database

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
National Tuberous Sclerosis Association 5,000
Testing effectiveness (Phase 2)Study completedNCT00457964
What this trial is testing

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Children's Hospital Medical Center, Cincinnati 36
Testing effectiveness (Phase 2)Study completedNCT03062943
What this trial is testing

Nintedanib for LymphAngioleioMyomatosis (LAM)

Who this might be right for
Lymphangioleiomyomatosis
IRCCS Multimedica 30
Testing effectiveness (Phase 2)WithdrawnNCT01690871
What this trial is testing

A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa

Who this might be right for
Malignant PEComa (Perivascular Epithelioid Cell Tumors)
Novartis Pharmaceuticals
Early research (Phase 1)Looking for participantsNCT06889168
What this trial is testing

Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)

Who this might be right for
Lymphangioleiomyomatosis (LAM)Lymphangioleiomyomatosis
Columbia University 20
Testing effectiveness (Phase 2)Study completedNCT03253913
What this trial is testing

Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 25
Not applicableUnknownNCT05785052
What this trial is testing

Biomarkers of Renal Cancer

Who this might be right for
Renal Cell CarcinomaTumor, SolidOncocytoma+1 more
Biorek S.R.L. 1,000
Testing effectiveness (Phase 2)UnknownNCT00490789
What this trial is testing

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Cardiff University 14
Testing effectiveness (Phase 2)Looking for participantsNCT06683846
What this trial is testing

Ivonescimab in the Treatment of Multiple Advanced Tumors

Who this might be right for
Pheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more
Fudan University 400
Next Page